Association between clinicopathological characteristics (CPC) and tumor types
| CPC | Case number | Intraductal carcinoma | Invasive carcinoma | χ2 | P value |
| Positive number (%) | Positive number (%) | ||||
| Age (years) | |||||
| ≤45 | 81 | 13 (72.7) | 68 (54.8) | 1.938 | 0.164 |
| >45 | 61 | 5 (27.8) | 56 (45.2) | ||
| Menopausal status | |||||
| Premenopausal | 80 | 9 (50.0) | 71 (57.3) | 0.337 | 0.562 |
| Postmenopausal | 62 | 9 (50.0) | 53 (42.7) | ||
| Pathologic types | |||||
| Ⅰ | 22 | 5 (27.8) | 17 (13.7) | 11.132 | 0.004 |
| Ⅱ | 61 | 12 (66.7) | 49 (39.5) | ||
| Ⅲ | 59 | 1 (5.6) | 58 (46.8) | ||
| Tumor size | |||||
| ≤3 cm | 72 | 15 (83.3) | 57 (46.0) | 8.87 | 0.003 |
| >3 cm | 70 | 3 (16.7) | 67 (54.0) | ||
| ER | |||||
| + | 73 | 14 (77.8) | 59 (47.6) | 5.738 | 0.017 |
| – | 69 | 4 (22.2) | 65 (52.4) | ||
| PR | |||||
| + | 79 | 15 (83.38) | 64 (51.6) | 6.408 | 0.011 |
| – | 63 | 3 (16.7) | 60 (48.4) | ||
| CerB2 | |||||
| + | 85 | 7 (38.9) | 78 (62.9) | 3.773 | 0.052 |
| – | 57 | 11 (61.1) | 46 (37.1) | ||
| Lymph node metastasis | |||||
| No | 73 | 17 (94.4) | 56 (45.2) | 15.283 | 0.000 |
| Yes | 69 | 1 (5.6) | 68 (54.8) | ||
| TNM stage | |||||
| Ⅰ+Ⅱ | 83 | 17 (36.4) | 66 (36.4) | 10.081 | 0.014 |
| Ⅲ+Ⅳ | 59 | 1 (1.7) | 58 (70.3) | ||
| EphA10 | |||||
| + | 8 (44.4) | 76 (61.3) | 1.846 | 0.174 | |
| – | 10 (55.6) | 48 (38.7) | |||
| Gli3 | |||||
| + | 9 (50.0) | 69 (55.6) | 0.202 | 0.653 | |
| – | 9 (50.0) | 55 (44.4) |
ER, estrogen receptor; PR, progesterone receptor; TNM, tumor lymph node metastasis.